After Hours
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Stocks Info
Royalty Pharma plc is listed on the NASDAQ in the Healthcare sector while operating in the Biotechnology industry. The current market capitalization of Royalty Pharma plc is $16.02B. A total of 1.81 million shares were traded on the day, compared to an average of 2.37M shares.
In the most recent transaction, RIGGS RORY B sold 235,200 shares of RPRX for 28.52 per share on Jan 02 ’24. After the transaction, the Director now owns 254,899 company shares. In a previous transaction on Jan 03 ’24, RIGGS RORY B sold 199,098 shares at 27.79 per share. RPRX shares that Director owns now total 55,801.
Among the insiders who sold shares, RIGGS RORY B disposed of 35,702 shares on Jan 04 ’24 at a per-share price of $27.55. This resulted in the Director holding 20,099 shares of RPRX after the transaction. In another insider transaction, Avara Management Ltd sold 65,803 shares at $28.04 per share on Dec 29 ’23. Company shares held by the 10% Owner now total 2,477,520.
Dividend
The reasons why investors prefer dividend-paying companies are that dividends generate immediate cash flow and indicate that the company will perform well in the future. Royalty Pharma plc pays an annual dividend of $0.83, resulting in a dividend yield of 3.07%, and it has a price to earnings (P/E) ratio of 17.97. RPRX’s most recent ex-dividend date was 11/15/2024 when it declared a $0.21 quarterly dividend that was paid in cash on 12/10/2024. Previously, the company paid the dividend on 9/13/2024 with an ex-dividend date of 8/16/2024. The RPRX stock dividend was $0.21 per share in cash.
Despite rarely being accurate, price targets can exert some form of influence at times, and are often regarded as valuable by markets. In terms of 52-week highs and lows, RPRX has a high of $31.66 and a low of $25.20.
Balance Sheet Annually/Quarterly
As well as showing the assets and liabilities of the company, the balance sheet also shows the amount invested in equity by investors. Investors can analyze a company’s future prospects by calculating its financial ratios based on this information. RPRX’s latest balance sheet shows that the firm has $2.80B in Cash & Short Term Investments as of fiscal 2021. There were $7.10B in debt and $171.25M in liabilities at the time. Its Book Value Per Share was $14.42, while its Total Shareholder’s Equity was $10.25B.
Analysts Opinion
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for RPRX is Buy with a score of 4.57.
